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a b s t r a c t
Gas chromatography/mass spectrometry (GC/MS) is the preferred technique for the detection of urinary
steroid androgens for drug testing in athletics. Excreted in either the glucuronide or sulfated conjugated
form, steroidsmust ﬁrst undergo deconjugation followed by derivatisation to render them suitable for GC
analysis. Discussedherein are thedeconjugation and thederivatisationpreparative options. The analyticalvailable online 31 January 2009
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challenges surrounding these preparatory approaches, in particular the inability to cleave the sulfate
moiety have led to a focus on testing protocols that reply on glucuronide conjugates. Other approaches
which alleviate the need for deconjugation and derivatisation are also highlighted.
© 2009 Elsevier B.V. Open access under CC BY license.econjugation
erivatisation
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. Introduction
The ever increasing desire of certain athletes to enhance their
erformance with the aid of anabolic and androgen drugs has been
Abbreviations: 13C/12C, stable carbon isotope ratio; APS, adenosine-5′-
hosphate; ATP, adenosine triphosphate; BSTFA, N,O-bis(trimethylsilyl)-triﬂuoro-
cetamide; DHEA, dehydroepiandrosterone; ES, external standard; FID, ﬂame
onisation detector; FU, Fishman unit; G, glucuronide; GC/C/IRMS, gas chromatog-
aphy/combustion/isotopic ratio mass spectrometry; GC/MS, gas chromatography/
ass spectrometry; IS, internal standard; IU, international unit; LC/MS, liquid
hromatography/mass spectrometry; L–L, liquid–liquid; MSTFA, N-methyl-N-
trimethylsilyl)-triﬂuoroacetamide; PAPS, 3′ ,5′-phosphoadenosine; P-Pi, pyrophos-
hate; S, sulfate; SPE, solid phase extraction; T/E ratio, testosterone to
pitestosterone ratio; TMCS, trimethylchlorosilane; TMIS, trimethyliodosilane; TMS,
rimethylsilyating; U, unit; UDPGA, uridine diphosphoglucuronic acid; RU, Roy unit;
ADA, World Anti-Doping Agency.
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E-mail address: rachel.gomes00@imperial.ac.uk (R.L. Gomes).
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met by the analytical chemist’s need to identify such cheats. Gas
chromatography/mass spectrometry (GC/MS) is the preferred ana-
lytical tool for quantifying urinary steroid androgens. However,
unresolved issues with determination lie in the preparative steps
necessary toenableGCanalysis of steroidandrogens [1]. Topromote
urinary excretion, steroids undergo phase II metabolism which
increases the hydrophilic nature of the steroid. This is achieved
by conjugation with either a glucuronide (Fig. 1) or sulfate (Fig. 2)
moiety. Less than 3% of the total androgens excreted via the urine
is unconjugated [2,3]. Conjugation of steroid androgens is gener-
ally with a glucuronide moiety. However, steroid androgens such
as androsterone, etiocholanolone, testosterone and epitestosterone
may also be excreted as sulfates, with a sulfate to glucuronide ratio
nearing 1:1 in some instances [4,5].5. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .For GC determination, the analyte of interest must be volatile
and thermally stable. Since steroid conjugates fulﬁl neither crite-
rion [6], preparative steps are required to render the conjugated
steroid amenable to GC analysis. This entails the conjugated
1134 R.L. Gomes et al. / Journal of Pharmaceutical and Biomedical Analysis 49 (2009) 1133–1140
Fig. 1. Conjugation of a glucuronide moiety to the free steroid androgen, testosterone [UDPGA, uridine diphosphoglucuronic acid].
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ﬁig. 2. Conjugation of a sulfate moiety to the free steroid androgen, testosterone
denosine-5′-phosphate].
teroid undergoing deconjugation or hydrolysis to produce the
ree steroid, followed by derivatisation to avoid poor chromato-
raphic performance. There are certain challenges that surround
hese preparatory approaches, in particular the ability to efﬁciently
leave the sulfatemoiety [7]. Therefore theanalytical focushasbeen
n the glucuronide conjugates which are far easier to hydrolyse.
An established list deﬁned by the World Anti-Doping Agency
WADA) documents the exogenous (e.g. nandrolone) and endoge-
ous (e.g. testosterone, dehydroepiandrosterone – DHEA) steroid
ndrogens [8]. An important indicator for steroid abuse is the
teroid proﬁle, of which the concentration ratio of testosterone
lucuronide to epitestosterone glucuronide (T/E ratio) has been
dopted for the detection of testosterone doping using gas chro-
atography/mass spectrometry (GC/MS). Being a minor product
f testosterone metabolism, epitestosterone does not increase
fter administration of testosterone, so a T/E ratio of ≥6.0 con-
titutes an offence. However, the threshold can be inﬂuenced by
everal metabolic and external parameters. This has resulted in
ADA guidance stating that urine samples should be submitted to
as chromatography/combustion/isotopic ratio mass spectrometry
GC/C/IRMS) if the T/E ratio is ≥4.0, or if concentrations are greater
han the set limits for testosterone, epitestosterone, androsterone,
tiocholanolone or DHEA (all derived from the glucuronide) [9].
y utilising GC/C/IRMS, stable carbon isotope ratios (13C/12C) allow
iscrimination between exogenous and endogenous steroids, the
xogenous origin containing less 13C than their endogenous homo-
ogues.
This paper reviews the options available for deconjugation and
erivatisation, along with the issues which have dictated the cur-
ent direction to steroid androgen analysis in the anti-doping
eld. Attention is also paid to two other approaches that allevi-3′ ,5′-phosphoadenosine; P-Pi, pyrophosphate; ATP, adenosine triphosphate; APS,
ate the need for the deconjugation and derivatisation steps are
also discussed, these being liquid chromatography/mass spectrom-
etry (LC/MS) which allows direct determination of the conjugate
and the potential of hydropyrolysis as a preparative technique for
GC/C/IRMS determination.
2. Deconjugation approaches
As conjugated steroids degrade under the high temperatures
required forGCanalysis, theﬁrst step is deconjugation or hydrolysis
of the steroid conjugate to its free form. Hydrolysis can be carried
out by biological (enzymatic) or chemical means (non-enzymatic).
Enzymatic methods are the approaches most commonly used [10].
There are three main sources of enzymes:
1. Mammalian: extracted from beef liver containing Ketodase,
2. Bacterial: from Escherichia coli and,
3. Molluscs: the most commonly used is Helix pomatia with lesser
used sources from the genera Patella (Patella vulgata), Haliotis
(abalone) and Ampullaria.
The mammalian and bacterial sources contain -glucuronidase
activity allowing cleavage of the glucuronide moiety. The mollusc
sources contain -glucuronidase and sulfatase activity, the latter
responsible for sulfate hydrolysis. Though all enzyme sources pos-
sess-glucuronidase activity, the amount of activity and speciﬁcity
varies. Ketodase was traditionally used for glucuronide hydrolysis
but has since been superseded by E. coli which is highly speciﬁc to
-glucuronides. To date, testing has focused on glucuronidase-only
hydrolysis, as exempliﬁed by the 2004 Summer Olympics held in
Athens which utilised E. coli [11].
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Unfortunately, hydrolysingonly theglucuronide conjugatesmay
ead to inaccuracies, as the ratio of glucuronide to sulfate excretion
f a steroid is dependent on the athlete’s metabolism and degree
f conversion to the sulfate conjugate [12,13]. A recent study of the
9-norsteroids identiﬁed that the contribution of sulfoconjugates
aried depending upon the individual and the drug administered.
he following metabolic possibilities were given [14]:
a. The absence of sulfoconjugates may occur in some individuals
and at some times during the metabolism,
. The amount of sulfates may exceed glucuronides during excre-
tion in the kidney,
c. Slower elimination of sulfoconjugates than glucuroconjugates
prior to excretion may explain the reversed proportions during
later excretion stages and,
. A delay of phase II metabolism of sulfate conjugates may occur.
Relative proportions of a steroid present as a sulfate conjugate
an be enhanced by drug administration. Doping with either 5-
ndrostane-3,17-diol or its precursor dihydrotestosterone leads
o marked increases in urinary epiandrosterone sulfate and 5
teroids [15]. The sulfate to glucuronide ratio can also be inﬂu-
nced by external factors such as ethanol consumption [16]. The
sefulness of determining sulfate conjugates is demonstrated with
he testosterone glucuronide to total epitestosterone (glucuronide
nd sulfate) ratio which has been proven to aid the discrimina-
ion between physiologically high and pharmacologically high T/E
lucuronide ratios [5].
Whilst hydrolysing sulfate in addition to glucuronide conjugates
s advantageous to detecting doping offences, a widely appli-
able deconjugation procedure is unavailable. The choice of a
eneral enzyme preparation can be difﬁcult owing to their high
peciﬁcity (Table 1). The efﬁcacy of enzymatic sulfate hydrolysis
an be affected by the carbon positioning of the sulfate moiety
nd the alpha/beta conﬁguration. H. pomatia is the most widely
sed enzyme preparation containing sulfatase activity and has the
roadest speciﬁcity. Comparatively, P. vulgata possesses weak sul-
atase activity which is highly speciﬁc for 3-hydroxy-5- and
3-hydroxy-5-steroids e.g. epiandrosterone and DHEA. How-
ver, neither preparation is able to hydrolyse 17 keto steroids
ulfates with 3- and 5-conﬁguration such as androsterone-3-
ulfate [17–19]. Steric hindrance is absolute when both the sulfate
n carbon 3 and hydrogen on carbon 5 are in the alpha position,
nd some hindrance is observed when both are in the  position
20]. Consequently, the enzymatic hydrolysis of a sulfate conjugate
roduces only a speciﬁc part of the total inventory.
In addition to incomplete sulfate hydrolysis, incubation with
. pomatia can also lead to steroid conversion or degrada-
able 1
everal issues arising from conjugate hydrolysis.
ssue Example
ncomplete deconjugation H. pomatia and P. vulgata una
testosterone-17-sulfate
teroid conversion/decomposition
Increase in testosterone with
DHEA to epiandrosterone wh
Decrease in DHEA which is co
Hot acid hydrolysis causes ste
ydrolysis conditions
DHEA sulfate deconjugation f
Decrease in androsterone and
temperatures for H. pomatia
The sulfatase activity of H. po
ydrolysis step in overall methodology
Inhibitors present in the urin
etiocholanolone glucuronides
Phosphate and sulfate ions in
Bacteria in the urine can metBiomedical Analysis 49 (2009) 1133–1140 1135
tion, and artefact formation. As well as glucuronidase and
sulfatase activity, H. pomatia contains other enzymes including
3-hydroxysteriod: NAD oxyreductase and 3-oxosteroid-5-4-ene-
isomerase [21]. On incubation with androst-5-ene-3,17-diol,
these additional enzymes produce a similar series of compounds
with a 17-hydroxy function, including testosterone. They are also
responsible for transforming DHEA to androst-4-ene-3,17-dione
which is a constituent in equine urine, as well as other artefacts
[22]. Hence, not only is the concentration of the steroid of inter-
est decreased but the product formed may adversely inﬂuence the
steroid proﬁle. Approaches to overcome the issues with H. pomatia
are areas of ongoing study and recently the use of sodium ascorbate
during hydrolysis with H. pomatia has been shown to improve the
steroid yield [23].
As well as deciding on the enzyme preparation, optimisation of
the hydrolysis conditions is of vital importance to ensure complete
deconjugation. The conditions which inﬂuence enzyme hydroly-
sis are the amount of enzyme, temperature, duration of incubation
and the pH. The enzyme activity must be sufﬁcient to enable com-
plete hydrolysis of the conjugates present in a sample. However,
the amount of enzyme required can be inﬂuenced by the type and
concentration of the steroid and the other hydrolysis conditions.
Additionally, the selectivity and reactivity of the enzyme prepa-
ration can vary depending on the source and/or batch [24]. The
enzyme activity expressed as either units, Fishman units or Roy
units for a particular preparation has been reported to be less
than that stated by themanufacturer [18]. Consequently, numerous
authors either test theenzymeactivityof thepreparationbeforeuse
or carry out preliminary studies to determine the optimumamount
of preparation required for complete hydrolysis. As the concentra-
tion of the steroid is obviously unknown, determining the correct
amount of enzyme is achievable by either a trial and error approach
or using excess enzyme. Unfortunately, the trial and error approach
is labour,money and time intensivewhilst using excess enzyme can
lead to a decrease in hydrolysis efﬁciency [25].
The choice of temperature for incubation is steroid-dependent.
Cleavage of DHEA sulfate is improved at higher temperatures
whilst androsterone and etiocholanolone sulfate deconjugation
is favoured at lower temperatures [19]. If these three steroids
were being assessed together, the sample would have to be
divided into aliquots prior to H. pomatia hydrolysis as recovery
of the latter two steroids is decreased when using the higher
temperatures [18]. The incubation duration is typically short
for hydrolysis with E. coli or Ketodase as cleavage of the glu-
curonides can occur within minutes [10]. However, a duration of
22h for E. coli has been cited in one recent study for testosterone,
epitestosterone, etiocholanolone, epiandrosterone, androsterone
and 5-androstane-3,17-diol [26]. For the enzymes possessing
References
ble to deconjugate androsterone-3-sulfate and [32]
H. pomatia from conversion of androst-5-ene-3,17-diol [34]
en using solvolysis [61]
nverted to androst-4-ene-3,17-dione with H. pomatia [22]
roid decomposition, resulting in low recoveries [37]
avours higher temperatures [19]
etiocholanolone recoveries using higher incubation [18]
matia is completely destroyed at pH 4.5 in acetate buffer [28]
e led to incomplete hydrolysis of androsterone and [30]
hibit steroid sulfatase [19]
abolise steroids [31]
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Table 2
Recent biological (enzyme) deconjugation approaches as part of the analytical method.
Analyte Enzymatic preparation Conditions for deconjugation Analytical procedure References
19-Norandrosterone Escherichia coli (K12 EC 3.2.1.31 Roche)
G activity not stated
Adjusted to pH 6.0, 50l E. coli added
then incubated at 40 ◦C for 1h.
Urine→ IS addition→hydrolysis→ L–L
extraction→ LC separa-
tion+ fractionation→derivatisation→
GC/MS
[44]
Testosterone, epitestosterone, androstenedione, DHEA,
androsterone, etiocholanlone
E. coli (K12 Boehringer Manneheim)
G=200 IUml−1
125ml of phosphate buffer (pH 7,
0.2M) added to 2ml urine. 50l E. coli
added and incubated at 50 ◦C for 1h.
Urine→ IS addition→hydrolysis→ L–L
extraction→derivatisation→GC/MS
[62] following
method in [63]
19-Norandrosterone, 19-noretiocholanolone,
19-norepiandrosterone
E. coli (Sigma), G activity not stated 1ml phosphate buffer (0.1M, pH 6.9)
and 50l E. coli added and incubated
at 50 ◦C for 1h.
Urine→ IS addition→ SPE
C18→hydrolysis→ chemical
hydrolysis→ L–L
extraction→derivatisation→GC/MS
[14]
Testosterone, epitestosterone, androsterone,
epiandrosterone, etiocholanolone, epietiocholanolone,
dihydrotestosterone, DHEA, 5-androstane-3,17-diol
E. coli (type VII-A Sigma),
G=5×103 Uml−1
200l urine diluted with 800l
potassium phosphate buffer (0.25M,
pH 6.9). 40l E. coli added and
incubated at 37 ◦C for 22h under gentle
agitation.
Urine→ IS addition→hydrolysis→ L–L
extraction →aqueous phase: SPE
C18→ chemical hydrolysis→ L–L
extraction→ LC/MS/MS, solvent phase:
LC/MS/MS
[26]
Testosterone, DHEA, 5-androstane-3,17-diol Helix pomatia (G0876 Sigma), G and S
activity not stated
10ml 0.05M acetate buffer (pH 5.5)
added. 250l H. pomatia, incubated
55 ◦C for 3h
Urine→ L–L extraction→ SPE
C18→hydrolysis→ L–L
extraction→ SPE silica→ LC separa-
tion+ fractionation→derivatisation→GC/
C/IRMS+GC/MS
[46]
Testosterone Helix pomatia (Biosepra) G=105
FUml−1, S = 106 RUml−1
2ml acetate buffer (pH 5.2) to 5ml
urine. 25l H. pomatia, incubated at
55 ◦C for 2h
Urine→ IS addition→hydrolysis→ SPE
C18→ L–L extraction→ SPE
oasis→derivatisation→GC/MS
[64]
Epitestosterone, etiocholanolone, DHEA Helix pomatia* (H-5 Sigma),
G=4–6×105 Ug−1,
S = 15–40×103 Ug−1
Adjusted to pH 5.2, incubated at
50–52 ◦C for 20h with 12,000U of
enzyme preparation.
Urine→ IS addition→hydrolysis→ SPE
C18→ silica gel puriﬁcation→ES
addition→derivatisation→GC/MS. (* Also
tested H. pomatia from Biosepra but enzyme
activity not stated.)
[10]
Patella vulgata (Sigma),
G=1–3×106 Ug−1, S =not determined
Adjusted to pH 6.8, incubated at 55 ◦C
for 20h with 12,000U of enzyme
preparation
Haliotis (abalone entrails) (Sigma)
G=4–8×105 Ug−1, S = 1–5×104 Ug−1
Adjusted to pH 5.2, incubated at 41 ◦C
for 20h with 12,000U of enzyme
preparation
Ketodase (Type B-1 Sigma),
G=5×105 Ug−1
Adjusted to pH 5.2, incubated at
50–52 ◦C for 1h with 12,000U of
enzyme preparation
Epitestosterone, etiocholanolone, DHEA Helix pomatia (Biosepra) G=105
FUml−1, S = 106 RUml−1
5ml of 2M acetate buffer (pH 5.2)
added to 50ml urine. 250l H.
pomatia, incubated at 52 ◦C for 20h.
Urine→hydrolysis→ SPE C18→ L–L
extraction→ silica gel puriﬁcation→ LC
separation+ fractionation→ES
addition→derivatisation→GC/C/IRMS and
GC/MS
[65]
Haliotis (abalone entrails) (Sigma),
G=4×105 Ug−1, S = 1–5×104 Ug−1
4.2ml of 0.2M acetate buffer (pH 5.2)
added to 50ml urine with 800l
abalone entrails, incubated at 42 ◦C for
20h.
[66]
DHEA, 5-androstane-3,17-diol,
androsterone, 5-androstane-3,17-diol,
etiocholanolone
Escherichia coli (Boehringer
Manneheim) G=80Uml−1
Glucuronides–25l of E. coli,
incubated at 50 ◦C for 1h.
Urine→ SPE C18 →anion exchange
fractionation→ sulfate
hydrolysis→glucuronide hydrolysis→ IS
addition→ L–L
extraction→derivatisation→GC/C/IRMS
[12]
Ampullaria (Nippon Bio-test),
G =4.2×104 FUml−1,
S = 2.1×104 RUml−1
Sulfates–30l of Ampullaria, incubated
at 60 ◦C for 1h.
DHEA: dehydroepiandrosterone; ES: external standard; FU: Fishman unit; G: glucuronide; GC/MS: gas chromatography/mass spectrometry; GC/C/IRMS: gas chromatography/combustion/isotope ratio mass spectrometry; IS:
internal standard; IU: international unit; L–L: liquid–liquid; LC: liquid chromatography; S: sulfate; SPE: solid phase extraction; U: unit; RU: Roy unit.
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Table 3
Recent chemical deconjugation approaches as part of the analytical method.
Analyte Hydrolysis preparation Conditions for deconjugation Analytical procedure References
19-Norandrosterone, 19-noretiocholanolone,
19-norepiandrosterone
Solvolysis (methanolysis) 1ml TMCS solution (1M TMCS in
methanol) was added to dried residue
and heated at 50 ◦C for 1h.
Urine→ IS addition→ SPE
C18→ enzyme hydrolysis→ chemical
hydrolysis→ L–L
extraction→derivatisation→GC/MS
[14]
DHEA, androsterone, etiocholanolone Solvolysis (methanolysis) 10% TMCS added to dry steroid sulfate
residue, heated at 50 ◦C for 30min then
cooled at room temperature.
Urine→ SPE PADII resin→ ion pairing
extraction→ SPE XAD-7→ chemical
hydrolysis→hexane
extraction→derivatisation→GC/MS
[7]
Testosterone, epitestosterone, epiandrosterone,
androsterone, etiocholanolone, dihydrotestosterone,
DHEA, 5-androstane-3,17-diol,
5-androstane-3,17-diol
Solvolysis (methanolysis) 1ml TMCS solution (1M TMCS in
methanol) was added to dried residue
and heated at 55 ◦C for 1h.
Urine→ IS addition→ SPE
C18*→hydrolysis→ L–L
extraction→derivatisation→GC/MS.
(*SPE eluate divided into two parts, one
for methanolysis and other for enzyme
hydrolysis using E. coli.)
[5,67]
Testosterone, epitestosterone, androsterone,
epiandrosterone, etiocholanolone,
epietiocholanolone, dihydrotestosterone, DHEA,
5-androstane-3,17-diol
Solvolysis 5ml ethyl acetate/H2SO4
(250ml/200mg, 98%) added to 1ml
SPE eluate. Heated for 1h at 55 ◦C
under mild agitation.
Urine→ IS addition→hydrolysis→ L–L
extraction →aqueous phase: SPE
C18→ chemical hydrolysis→ L–L
extraction→ LC/MS/MS, solvent phase:
LC/MS/MS
[26]
DHEA Hot acid hydrolysis
(combined with
derivatisation step)
50l each of acetone, acetic anhydride
and acetic acid added to dried residue.
Heated at 100 ◦C for 3h.
Urine→ SPE C18→ enzyme hydrolysis
(E. coli)→ SPE C18→ chemical
hydrolysis +derivatisation→ SPE
C18→GC/MS
[39]
Androsterone, etiocholanolone, DHEA Hot acid hydrolysis
(combined with solvent
extraction)
10ml benzene and 2ml HCl added to
dried residue. Reﬂuxed at 80–83 ◦C for
20min.
Urine→ IS addition→ L–L
extraction→hydrolysis + solvent
extraction→derivatisation→GC–FID
[36]
DHEA: dehydroepiandrosterone; FID: ﬂame ionisation detector; GC/MS: gas chromatography/mass spectrometry; GC/C/IRMS: gas chromatography/combustion/isotope ratio mass spectrometry; IS: internal standard; L–L:
liquid–liquid; LC: liquid chromatography; SPE: solid phase extraction; TMCS: trimethylchlorosilane.
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lucuronidase and sulfatase activity, incubation periods of between
and 20h have been utilised (Table 2). As high throughput analy-
is is necessary for sports testing, especially during competitions,
he long incubation times for hydrolysis can make their ability to
ontribute to a screening method unfeasible.
Hydrolysis is also pH-dependent and varies depending on the
nzyme preparation utilised. The concentration of the conjugates
resent in the sample can affect the pH and thus can vary from
rine to urine [18]. The pH of common hydrolysis conditions is gen-
rally slightly acidic to neutral as androgen glucuronides are more
esistant tohydrolysis under alkaline conditions [27]. The conjugate
oiety also plays a role with H. pomatia requiring an optimum pH
.5–5.0 for -glucuronidase and pH>6.2 for sulfatase activity. The
ctivity of H. pomatia is completely destroyed at pH 4.5 in acetate
uffer [28].
The literature reveals that optimisation of the conditions are
arried out one parameter at a time. However, this can lead to
nreliable results as interactions between the conditions can occur.
sing H. pomatia, P. vulgata, Haliotis entrails and Ketodase, a com-
arative study investigating the optimum hydrolysis conditions
or DHEA, etiocholanolone and epitestosterone were performed
sing a response surface methodology [10]. The mathematical
pproach allowed for interactions between different conditions to
e assessed and illustrated the complexity of determining suitable
ydrolysis conditions. Using Haliotis entrails, hydrolysis was inﬂu-
ncedby temperature and the amount of enzymeused. Interactions
etween temperature and time also affected hydrolysis. In contrast,
time–pH interaction existed for P. vulgata and was steroid and
nzyme amount dependent. Effects could also be quadratic as with
he case of pH for etiocholanolone or linear as observed for the
H effect on DHEA when using H. pomatia. The study concluded
hat Haliotis entrails were the best enzymatic preparation for the
teroids investigated. Despite the inﬂuence that the conditions for
ydrolysis can have on efﬁcient cleavage, there have been publi-
ations which do not state the supplier nor conditions for enzyme
ydrolysis [29].
In addition to the ambiguity over the enzyme choice and the
onditions for enzymatic hydrolysis, there is also disparity over
hether to hydrolyse pre- or post-extraction from urine. Origi-
ally, extraction followed by hydrolysiswas the preferred approach
ut the majority of more recent studies favour direct hydrolysis
pre-extraction) on the urine (Table 2). However, direct hydroly-
is has been shown to lead to incomplete hydrolysis or decreased
ecovery of the steroids of interest. Incomplete hydrolysis has been
bserved for androsterone and etiocholanolone glucuronides and
his inefﬁciency, which was irrespective of the enzyme prepara-
ion used (Ketodase, E. coli or H. pomatia), and appeared to be
elated to undeﬁned inhibitors present in the urine [30]. Cleavage
f the sulfate moiety can be adversely affected owing to phosphate
nd sulfate ions inhibiting steroid sulfatase [19]. Bacteria may also
etabolise someof the analytes during the enzyme incubation step
31]. Removal of interfering compounds by extraction followed by
ydrolysis can lead to improved hydrolysis even when using less
nzyme [25]. This is particularly pertinent with DHEA, with a bal-
nce between sufﬁcient enzyme preparation for complete cleavage
f the sulfatemoiety but not to such an excess as to give insufﬁcient
ecovery of DHEA.
As many sulfate conjugates are resistant to enzyme hydroly-
is or generate unwanted by-products, the less speciﬁc chemical
ydrolysis as an alternative to the sulfatase enzyme has been intro-
uced. Chemical hydrolysis can be used either in combination with
n enzymepreparation (commonly E. coli) or on an individual basis.
raditionally, chemical hydrolysis was achieved using hot acid with
leavage of the conjugate being strongly inﬂuenced by the choice
f acid (hydrochloric or sulfuric), acid molarity, temperature and
uration of the reaction [32]. More recently, chemical hydroly-Biomedical Analysis 49 (2009) 1133–1140
sis has been carried out by solvolysis and when compared to hot
acid hydrolysis, leads to superior steroid recovery [33]. Solvoly-
sis can utilise ethyl acetate in acidic conditions and heating for
anything between 1h at 55 ◦C [26], and 24–48h at 37 ◦C [18,34].
Alternatively, methanolysis which is a variation of solvolysis using
trimethylchlorosilane (TMCS) in methanol has been employed for
a wide range of steroid androgens (Table 3). Cleavage of both the
glucuronide and sulfated conjugates occurs due to the generation
of hydrochloric acid from TMCS which then promotes hydrolysis
[5].
Chemical hydrolysis is not without issues and may cause degra-
dation of some analytes, increased levels of co-extractants, and
increasedmatrix interference fromdegradation ofmacromolecules
[35]. To remove matrix effects, chemical hydrolysis is performed
following extraction of the steroid conjugates from the urine. Acid
hydrolysis applied directly to urine is particularly undesirable lead-
ing to the formationof compounds fromtheactionof the acidon the
organic urine components [36]. Hot acid is generally now consid-
ered unreliable, in particular for DHEA sulfate due to low recoveries
caused by steroid decomposition [37,38]. However, a recent study
utilised hot acid in a one step hydrolysis-derivatisation procedure
for DHEA sulfate (recovery not reported) [39].
To summarise, the issueswith efﬁcient sulfate hydrolysis has led
to a focus on glucuronide-only analysis utilising E. coli which does
not form unwanted by-products. For sulfate hydrolysis or samples
containing both moieties, the choice of method is inﬂuenced by the
steroids of interest. One of three approaches has been employed:
1. Enzyme hydrolysis using H. pomatia,
2. Chemical hydrolysis by solvolysis, or
3. Combination of E. coli followed by solvolysis.
However, there is no consensus over the conditions for either
enzyme or chemical hydrolysis and to date; no universal method
for steroid deconjugation is available.
3. Derivatisation
Following hydrolysis and extraction, urinary steroids require
derivatisation prior to analysis by GC to improve their volatility,
thermal stability and peak shape thus enhancing separation and
detection. Most importantly, this approach means that it is not the
conjugate or free steroid that is actually determined but rather a
chemically modiﬁed form. Despite this disadvantage and the fact
that derivatisation is considered to be a laborious task, GC/MS(/MS)
is one of themostwidely usedmethods formeasuring steroids orig-
inally present in urine as conjugates [40]. Derivatisation of steroids
can be carried out using silyation or acylation reactions, depending
on the individual properties of the steroid and detection system.
The choice of derivatisation mixture is dependent on the steroids
of interest, as co-elution of the derivatised steroids may occur [41].
Silyation is the preferred steroid derivatisation approach
for GC/MS with a variety of trimethylsilyating (TMS) reagents
being available. The most popular are the N,O-bis(trimethylsilyl)-
triﬂuoroacetamide (BSTFA) and the more volatile N-methyl-N-
triﬂuoroacetamide (MSTFA). The use of catalysts is very common
in the silylation process and necessary for tertiary hydroxyl groups
andenolisationof the carbonyl function [42]. Enolisationof the keto
group can be achieved by acylation with acid anhydride or silyla-
tion combining a silylating reagent and a catalyst such as potassium
acetate or the more traditional trimethyliodosilane (TMIS) [43].
As TMIS is highly sensitive to hydrolysis and decomposition by
oxygen and light, a reduction agent (ethanethiol, dithiothreitol or
2-mercaptoethanol) is often added to minimise iodine formation
and postpone degradation of the derivatisation mixture.
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A derivatisation procedure using MSTFA with ethanethiol and
mmonium iodide (as an alternative to TMIS) suitable for GC/MS
nalysis has been routinely used by the WADA-accredited labora-
ories for athletic drug testing [44]. However, this derivatisation
ixture may lead to the formation of ethyl thio adducts which can
ause interpretation problems in sample analysis [41]. The failure
f some steroids to provide a single reaction product, together with
he chemical rearrangement of others, has been cited as ahindrance
o ofﬁcial testing laboratories [45].
Whereas silyation has been the accepted precursor step for
C/MS(/MS), silyation reagents are considered incompatible with
C/C/IRMS due to deposition of silicon on the copperwire resulting
n incomplete combustion. Acetylation is the standard derivatisa-
ion approach for GC/C/IRMS, with the derivatised products being
ery stable and exhibiting good chromatographic properties. The
onsequence of derivatisation for GC/C/IRMS determination is the
ddition of carbon atoms at each derivatised site. The fewer car-
ons added the less impact on the overall carbon isotope ratio. For
cetylation, only two carbon atoms are added compared to three for
ilylation, due to derivatisation of just the hydroxyl groups and not
he enols [46]. However one study identiﬁed incomplete derivatisa-
ion resulting in mixtures of non-, mono- and diacetylated steroids
47]. Consequently, the study evaluated the derivatisation mixture
f MSTFA, dithiothreitol and TMIS on etiocholanolone, epiandros-
erone, epitestosterone and DHEA. Poor reproducibility for DHEA
sing TMIS was observed with variation in the number of TMS
roups but replacing TMIS with ammonium iodide gave well-
esolved chromatographic signals, no peak tailing, reproducible
easurements and a good signal-to-noise ratio [47].
. LC/MS(/MS) and new techniques
In addition to the issues raised above, the hydrolysis and
erivatisation steps also add time and expense to the overall
ethodology. To alleviate these problems and more importantly
llow analysis of steroid sulfates without the problems associated
ith hydrolysis, an alternative analytical approach has gained pop-
larity. LC/MS(/MS) allows for direct determination of the steroid
onjugate, negating modiﬁcation of the analyte structure to ren-
er it suitable for analysis (Fig. 3). Without the need for hydrolysis
r derivatisation, the sample preparation time is greatly reduced
eading to a reduction in analyte losses [48]. A review of the recent
iterature illustrates that steroid sulfate determination is important
o the anti-doping ﬁeld and the use of LC/MS(/MS) is a valuable tool
o achieving this goal [49–52]. However, though LC/MS(/MS) may
e utilised, hydrolysis of glucuronide and sulfated conjugates may
till be employed [26].
LC/MS(/MS) is not, however, completely infallible and can suf-
er from ionisation and matrix effects leading to poor responses
n conjugate quantiﬁcation [53–56]. In addition and of particu-
Fig. 3. Overview of analytical methodologies for steroid determination.
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lar relevance to the anti-doping ﬁeld, whilst LC/MS can be used
in place of GC/MS for determining the steroid proﬁle, elucidating
whether the steroid is exogenous or endogenous is still the premise
of GC/C/IRMS.
Recently, a preparatory technique which renders steroid conju-
gates suitable for GC analysis without the need for hydrolysis or
derivatisation has been developed. Originally utilised for liberating
organic matter from petroleum source rocks [57], hydropyrolysis
involves stripping the functional groups from steroids whilst faith-
fully retaining the carbon skeleton and its stereochemistry [58].
This approach has now been applied to fatty acids and free and
conjugated steroids with determination by GC/C/IRMS [58–60].
5. Conclusions
The anti-doping ﬁeld has many tools for analysing steroids rele-
vant to substance abuse. The primary analytical tool is GC coupled
to MS or IRMS as advocated by WADA. The preparative approaches
of hydrolysis and derivatisation are a necessary prerequisite for GC
determination.Unfortunately, the choice of hydrolysis is dependent
on the steroid and conjugate moiety. Even then, the hydrolysis con-
ditions are not deﬁned and are often inefﬁcient. Derivatisation also
lacks auniversal approachand can lead to chemical rearrangements
and multiple reaction products. These issues have limited the focus
to steroids conjugated with a glucuronide moiety. Though deter-
mining steroid sulfates continue to be of interest in the anti-doping
ﬁeld, the current direction for analysing the sulfated conjugates is
by LC/MS(/MS) which alleviates the need for hydrolysis or derivati-
sation. Determining whether the steroidal origin is endogenous
or exogenous is of vital importance and necessitates GC/C/IRMS.
A new preparatory technique termed hydropyrolysis exhibits the
potential to analyse both glucuronide and sulfated conjugateswith-
out the need for hydrolysis or derivatisation. By removing the
functional groups to leave a carbon skeleton, its amenability to
GC/C/IRMS analysis will allow conclusive determination of the ori-
gin of steroids.
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